Oruka Therapeutics (ORKA) Interest Coverage Ratio Growth (3y) (2013 - 2022)
Powered by 
Analysis
Oruka Therapeutics (ORKA) Interest Coverage Ratio Growth (3y) (2013 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 11.97% |
| Mar 31, 2022 | -40.27% |
| Sep 30, 2020 | 23.67% |
| Jun 30, 2020 | 46.04% |
| Mar 31, 2020 | 46.52% |
| Sep 30, 2018 | 33.43% |
| Jun 30, 2018 | 19.14% |
| Mar 31, 2018 | 30.42% |
| Sep 30, 2017 | 0.70% |
| Jun 30, 2017 | -4.93% |
| Mar 31, 2017 | 2.86% |
| Sep 30, 2015 | -44.79% |
| Jun 30, 2015 | -33.41% |
| Mar 31, 2015 | -24.97% |
| Sep 30, 2014 | -35.89% |
| Jun 30, 2014 | -41.35% |
| Mar 31, 2014 | -75.73% |
| Dec 31, 2013 | -7.81% |
| Jun 30, 2013 | 19.18% |